Stock Comparison

ECOR vs UNH

electroCore, Inc. vs UnitedHealth Group Inc

The Verdict

ECOR takes this one.

Winner

ECOR

electroCore, Inc.

2.5

out of 10

Risk Trap

UNH

UnitedHealth Group Inc

0.3

out of 10

Distressed

Head-to-Head

$79M

Market Cap

$365.5B

N/A

P/E Ratio

30.3

-44.1%

Profit Margin

2.7%

-235.8%

Return on Equity

12.4%

N/A

Debt-to-Equity

0.8

Aggressive

Overall Risk

Moderate

2.5

DVR Score

0.3

The Deep Dive

ECOR2.5/10

electroCore exhibits strong operational execution, evidenced by Q1 2026 revenue of $9.6M, representing a 42.64% YoY increase, and its gammaCore device addresses a vast market for headache disorders with patented, non-invasive technology. This market potential and product strength are compelling. However, these positives are severely undermined by critical financial distress. The company faces pers...

Full ECOR Analysis

UNH0.3/10

UnitedHealth Group (UNH) remains a robust, high-quality mega-cap in the mature and highly regulated healthcare sector. Q1 2026 adjusted EPS of $7.23, a recent dividend increase to $2.32, and some analyst upgrades (e.g., Truist to $440, Goldman Sachs Conviction Buy) reflect solid operational performance and financial strength. However, these are characteristics of a stable compounder, not a company...

Full UNH Analysis

Want More Comparisons?

Run any stock through our deep value analyzer.

Analyze Any Stock →

Not Financial Advice

This comparison is for educational purposes only. We are not financial advisors. Always do your own research and consult a qualified advisor before investing.